Literature DB >> 4294312

Ocular complications of vincristine therapy.

D M Albert, V G Wong, E S Henderson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4294312     DOI: 10.1001/archopht.1967.00980030711004

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


× No keyword cloud information.
  8 in total

1.  Retinal pigment epithelial degeneration, partial retinal atrophy and macular hole in acute lymphocytic leukemia.

Authors:  D M Inkeles; A H Friedman
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1975

2.  Ocular toxicity from systemic drug therapy. An overview of clinically important adverse reactions.

Authors:  S I Davidson; I G Rennie
Journal:  Med Toxicol       Date:  1986 May-Jun

Review 3.  Continuous remission of newly diagnosed and relapsed central nervous system atypical teratoid/rhabdoid tumor.

Authors:  Mary Ann Zimmerman; Liliana C Goumnerova; Mark Proctor; R Michael Scott; Karen Marcus; Scott L Pomeroy; Christopher D Turner; Susan N Chi; Christine Chordas; Mark W Kieran
Journal:  J Neurooncol       Date:  2005-03       Impact factor: 4.130

4.  [A histological and electron microscopic study of the rabbit retina after application of vincristin (author's transl)].

Authors:  G Koniszewski; R Rix; P Brunner
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1976-04-14

Review 5.  [Oculomotor, trochlear, and abducens nerve palsies].

Authors:  F Staubach; W A Lagrèze
Journal:  Ophthalmologe       Date:  2007-08       Impact factor: 1.059

6.  Retinal and optic nerve atrophy induced by intravitreous vincristine in the primate.

Authors:  W R Green
Journal:  Trans Am Ophthalmol Soc       Date:  1975

Review 7.  Clinically important ocular reactions to systemic drug therapy.

Authors:  I G Rennie
Journal:  Drug Saf       Date:  1993-09       Impact factor: 5.606

8.  Bilateral optic neuropathy following vincristine chemotherapy: A case report with description of multimodal imaging findings.

Authors:  Woo Hyuk Lee; Sun Kyoung You; Yeon-Hee Lee
Journal:  Medicine (Baltimore)       Date:  2021-03-05       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.